Randomized trial about cardiovscular (CV) complications in patients with advanced PC & CV disease treated with GnRH agonist or antagonists.

[tango65]

Cardiovascular morbidity in a randomized trial comparing GnRH-agonist and GnRH-antagonist among patients with advanced prostate-cancer and pre-existing cardiovascular disease.

auajournals.org/doi/10.1097...

Less CV complications in patients treated with antagonists.

[6357axbz]

Is my understanding of terminology correct that these results favor degaralix (firmanon) over Lupron (Eligard)?

[tango65 in reply to 6357axbz]

Yes, you are correct.

[Hidden]

I would like to know how casodex scores in this context.